Clinical Trial Update: Treatment for Anemic Subjects With Non-Myeloid Malignancies Receiving Chemotherapy [Phase 2]

View source ↗

Summary

Amgen reports a completed Phase 2 trial evaluating a treatment for anemia in patients with solid tumors receiving chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Cancer

Snippet

Sponsor: Amgen | Conditions: Neoplasms, Anemia | Phase 2 | Status: COMPLETED